Literature DB >> 12060342

The neuropathology and pathogenesis of systemic lupus erythematosus.

N J Scolding1, F G Joseph.   

Abstract

Systemic lupus erythematosus (SLE) is a chronic, multisystem, autoimmune disease in which neuropsychiatric involvement occurs in about 50% of patients and carries a poor prognosis. Despite extensive research, the precise mechanisms of nervous tissue injury remain the least well understood. This article summarizes the important clinical neuropsychiatric features of SLE and, reviewing classical histopathological and more recent experimental studies, discusses theories concerning their presumed pathogenesis. The distinctive production of diverse autoantibodies seems to be related to defective clearance of apoptotic cells. Antibody-mediated neural cell injury and rheological disturbances represent the two principal suggested mechanisms of tissue injury. An interplay between these processes, underlying genetic factors, their modification by hormones, complicated by a number of secondary factors, may explain the wide spectrum of features encountered in this disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12060342     DOI: 10.1046/j.1365-2990.2002.00406.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  20 in total

Review 1.  A model for lupus brain disease.

Authors:  Betty Diamond; Bruce T Volpe
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

Review 2.  Neuroimmunopathology in a murine model of neuropsychiatric lupus.

Authors:  David A Ballok
Journal:  Brain Res Rev       Date:  2006-12-20

3.  Human lupus autoantibodies against NMDA receptors mediate cognitive impairment.

Authors:  Czeslawa Kowal; Lorraine A Degiorgio; Ji Y Lee; Mark A Edgar; Patricio T Huerta; Bruce T Volpe; Betty Diamond
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-14       Impact factor: 11.205

4.  Glutamate receptor biology and its clinical significance in neuropsychiatric systemic lupus erythematosus.

Authors:  Cynthia Aranow; Betty Diamond; Meggan Mackay
Journal:  Rheum Dis Clin North Am       Date:  2010-02       Impact factor: 2.670

Review 5.  Lupus brain fog: a biologic perspective on cognitive impairment, depression, and fatigue in systemic lupus erythematosus.

Authors:  Meggan Mackay
Journal:  Immunol Res       Date:  2015-12       Impact factor: 2.829

6.  Neuroimaging evidence of white matter inflammation in newly diagnosed systemic lupus erythematosus.

Authors:  Amy E Ramage; Peter T Fox; Robin L Brey; Shalini Narayana; Matthew D Cykowski; Mohammad Naqibuddin; Margaret Sampedro; Stephen L Holliday; Crystal Franklin; Daniel J Wallace; Michael H Weisman; Michelle Petri
Journal:  Arthritis Rheum       Date:  2011-10

7.  Assessing "occult" cervical cord damage in patients with neuropsychiatric systemic lupus erythematosus using diffusion tensor MRI.

Authors:  Beatrice Benedetti; Marco Rovaris; Elda Judica; Giovanni Donadoni; Gianfranco Ciboddo; Massimo Filippi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-03-19       Impact factor: 10.154

8.  A role for the B-cell CD74/macrophage migration inhibitory factor pathway in the immunomodulation of systemic lupus erythematosus by a therapeutic tolerogenic peptide.

Authors:  Smadar Lapter; Hava Ben-David; Amir Sharabi; Heidy Zinger; Alona Telerman; Maya Gordin; Lin Leng; Richard Bucala; Idit Shachar; Edna Mozes
Journal:  Immunology       Date:  2010-08-25       Impact factor: 7.397

9.  Markers of acute neuropsychiatric systemic lupus erythematosus: a multidisciplinary evaluation.

Authors:  Essam A Abda; Zahraa I Selim; Moustafa E M Radwan; Nagham M Mahmoud; Omar M Herdan; Khalid A Mohamad; Sherifa A Hamed
Journal:  Rheumatol Int       Date:  2012-10-12       Impact factor: 2.631

10.  Comparison of the clinical manifestations, brain MRI and prognosis between neuroBeçhet's disease and neuropsychiatric lupus.

Authors:  Byung-Sik Cho; Hyun-Sook Kim; Su-Jin Oh; Hyeok-Jae Koh; Chong-Hyun Yoon; So-Lyung Jung; Do-June Min; Wan-Uk Kim
Journal:  Korean J Intern Med       Date:  2007-06       Impact factor: 3.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.